Why Unilever plc & Reckitt Benckiser Group Plc Are Now Too Expensive For Me

Roland Head explains why he believes Unilever plc (LON:ULVR) and Reckitt Benckiser Group Plc (LON:RB) are now too expensive for new investors.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Consumer goods giants Unilever (LSE: ULVR) (NYSE: UL.US) and Reckitt Benckiser (LSE: RB) (NASDAQOTH: RBGLY.US) are regularly cited as examples of firms where you pay a premium for quality.

Until recently, I’ve agreed with this view: in recent years I’ve purchased shares in Unilever at around 2,000p and 2,400p, and have no intention of selling them.

However, shares in both companies have climbed by between 15% and 20% over the last 12 months, and I’ve reached my limit: I won’t buy either firm at today’s prices.

Why not?

Unilever and Reckitt don’t seem to be able to meet City expectations — consensus forecasts for Unilever’s 2015 earnings have fallen from 148p to 134p over the last twelve months, leaving the firm on a 2015 forecast P/E of almost 21.

That seems too high, to me, given that in its 2014 results, Unilever warned that market conditions were not expected to improve significantly in 2015.

It’s a similar story at Reckitt, which currently trades on a 2015 forecast P/E of 23 times and offers a prospective yield of just 2.4%.

In fairness, I think the problem might be that City forecasts are too optimistic: Unilever and Reckitt have been quite open about soft conditions emerging markets in their trading updates.

Changing shape

Neither company is standing still in the face of sub-par growth.

Reckitt demerged its pharmaceuticals business into a new London-listed firm, Indivior, earlier this year, in order to sharpen its focus on its core health and hygiene ranges.

Back in December, Unilever said it would move its slow-growing spreads and margarines business into a standalone unit, a move widely seen as a precursor to a sale of this business. This would enable Unilever to focus more heavily on personal care products where profit margins and sales growth are higher.

How much would I pay?

Unilever’s adjusted earnings per share have grown by an average of less than 5% since 2009, while the equivalent figure for Reckitt is 11%.

In my view, Unilever would be more reasonably valued on a P/E of 17, which would give a yield of about 4%, and a share price of around 2,300p.

Reckitt has delivered strong growth and enjoys higher operating profit margins than Unilever, but earnings are expected to fall this year. I’d be happy to pay around 4,500p for Reckitt, which would equate to a 2015 P/E of 18, and a prospective yield of around 2.9%.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Roland Head owns shares in Unilever. The Motley Fool UK owns shares of Unilever. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Concept of two young professional men looking at a screen in a technological data centre
Investing Articles

If I’d put £5,000 in Nvidia stock at the start of 2024, here’s what I’d have now

Nvidia stock was a massive winner in 2023 as the AI chipmaker’s profits surged across the year. How has it…

Read more »

Light bulb with growing tree.
Investing Articles

3 top investment trusts that ‘green’ up my Stocks and Shares ISA

I’ll be buying more of these investment trusts for my Stocks and Shares ISA given the sustainable and stable returns…

Read more »

Investing Articles

8.6% or 7.2%? Does the Legal & General or Aviva dividend look better?

The Aviva dividend tempts our writer. But so does the payout from Legal & General. Here he explains why he'd…

Read more »

a couple embrace in front of their new home
Investing Articles

Are Persimmon shares a bargain hiding in plain sight?

Persimmon shares have struggled in 2024, so far. But today's trading update suggests sentiment in the housing market's already improving.

Read more »

Market Movers

Here’s why the Unilever share price is soaring after Q1 earnings

Stephen Wright isn’t surprised to see the Unilever share price rising as the company’s Q1 results show it’s executing on…

Read more »

Investing Articles

Barclays’ share price jumps 5% on Q1 news. Will it soon be too late to buy?

The Barclays share price has been having a great time this year, as a solid Q1 gives it another boost.…

Read more »

Young black colleagues high-fiving each other at work
Investing Articles

The AstraZeneca share price lifts 5% on a top-and-bottom earnings beat

The AstraZeneca share price reached £120 today and helped push the FTSE 100 higher. Would I still buy this flying…

Read more »

Young black woman using a mobile phone in a transport facility
Market Movers

Meta stock slumps 13% after poor results. Here’s what I’ll do

Jon Smith flags up the reasons behind the fall in the Meta stock price overnight, along with his take on…

Read more »